Plavix Side Effect Lawsuit
Plavix has been marketed extensively throughout the United States by its manufacturer Bristol-Myers Squibb Sanofi as a prescription drug advertised to be more effective than Aspirin in treating heart disease.
In fact, studies have shown that Plavix has almost no positive effect beyond Aspirin. Recent studies have also concluded that Plavix patients may be responsible by a factor of ten against non Plavix patients in being diagnosed with ulcers due to its use. Plavix may cause bleeding ulcers.
A recent study in the New England Journal of Medicine concluded that the combination and Plavix and Aspirin did not help or prevent a second heart attack but increased the risk of heart attack or stroke with patients who have no prior cardiovascular history. The study concluded that the cost and risk of Plavix is not merited for the prevention of coronary artery disease and heart attacks.
We are reviewing Plavix side effect claims throughout the country of those who suffered heart attacks, strokes, ulcers, internal bleeding and blood disorders while on Plavix.
If you or a loved one has taken Plavix and experienced these side effects which include gastrointestinal bleeding, heart attacks, strokes please contact us immediately. You may be entitled to a financial recovery against the manufacturer.
Remember, Plavix has been marketed to such an extent that it is now the sixth top selling drug with sales totaling over 3.8 billion dollars. It is used in combination with Aspirin commonlyprescribed as a preventative measure against strokes and heart attacks. Unfortunately, the reverse may be true due to the above referenced conclusions of the New England Journal of Medicine study.
Plavix has been associated with the following side effects:
- Gastrointestinal and cerebral bleeding or ulcers
- Heart attack
- Irregular heartbeat
Please contact us to see if you have a Plavix legal claim. Our defective drug litigation division is a highly experienced team of lawyers, doctors, expert witnesses, paralegals who represent and handle prescription drug side effect victims nationwide. We are currently accepting new Plavix cases in all 50 states.
In order to obtain a free review of your potential case please complete the email on the right. A qualified member of the firm will respond to you within 12 hours.
Please call or email us today.
Our law firm handles cases throughout the entire United States including:
Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut,
Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa,
Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan,
Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New
Hampshire, New Jersey, New Mexico, New York, North Carolina, North
Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South
Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia,
Washington, West Virginia, Wisconsin and Wyoming.
Our lawyers and co-counsel also represent actively clients in the following cities: Los Angeles, San Diego, San Francisco, Fresno, Bakersfield, San Bernardino, Riverside, Sacramento, Santa Rosa, Santa Barbara, Santa Maria, Oxnard, Ventura, New York, Chicago, Houston, Phoenix, Philadelphia, San Antonio, El Paso, San Diego, Dallas, San Jose, Detroit, Jacksonville, Indianapolis, Salt Lake City, Reno, Las Vegas, Columbus, Austin, Memphis, Fort Worth, Baltimore, Washington D.C., Ann Arbor, Charlotte, Boston, Seattle, Pensacola, Orlando, Miami, Milwaukee, Seattle, Spokane, Salem, Oregon, Portland, Denver, Louisville, Nashville, Memphis, Oklahoma City, Albuquerque, Santa Fe, Phoenix, Tuscon, Portland, Atlanta, Long Beach, Mesa, Kansas City, Cleveland, Richmond, Omaha, Miami, Oakland, Tulsa, Honolulu, Minneapolis, Colorado Springs, Arlington, Wichita, Bismark, Boise.
Attorney Advertising – Trademark Notice: the use of the term Plavix® is strictly for identification purposes and Attorney Advertising. Plavix® is a registered trademark of Bristol-Myers Squibb Sanofi. Nadrich & Cohen LLP is in no way affiliated with Bristol-Myers Squibb Sanofi.